As millions of people worldwide seek ways to manage their diabetes, the continuous glucose monitor (CGM) market continues to grow rapidly.
Medtech market analysts project significant growth for the market over the next five years. Chrystal Larsen, a veteran medtech market analyst, produced a detailed report for MassDevice outlining the future of the CGM market.
The report covers competitive analysis/market share, leading competitors and emerging startups, corporate strategies, market drivers and limiters, and trends/opportunities and plenty more.
Visit here to purchase the report.
The most common CGMs on the market today are wearable sensors attached to the skin that can detect blood glucose levels in the interstitial fluid, delivering alerts and pairing with smart devices and automated insulin delivery systems. They can identify potentially dangerous glucose levels and provide useful information on patterns as a response to diet and exercise.
Some of the world’s biggest medical device makers lead the way in the CGM market, with Abbott, Dexcom, Medtronic, Senseonics and more developing their own platforms, and, even on rare occasions, partnering with one another. More entrants are making their plays, including with new technologies like long-term implants in addition to new biosensors. Additionally, companies like Abbott and Dexcom have made their CGMs available over the counter, potentially reaching even more people.
The market is expected to grow substantially over the next five years, including double-digit percentage growth that could enable it to reach $28.9 billion in 2030.
This extensive report includes epidemiology data, clinical overview, medical device technologies and innovations, historical sales and forecast markets, growth rates by region (U.S. and international), and more.
